Cogstate Limited

Headquarters: Fitzroy, VIC, Australia

Employees: 170

CEO: Mr. Bradley O'Connor C.A., B.Bus, CA

ASX: CGS +2.71%

Market Cap

A$242.5 Million

AUD as of Jan. 1, 2024

US$165.2 Million

Market Cap History

Cogstate Limited market capitalization over time

Evolution of Cogstate Limited market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Cogstate Limited

Detailed Description

Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain health applications in Australia and internationally. The company's services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist in the early detection of cognitive decline. As of June 30, 2021, it had participated in approximately 1,800 academic research studies in approximately 200 indications. Cogstate Limited was incorporated in 1999 and is based in Fitzroy, Australia.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Cogstate Limited has the following listings and related stock indices.

Stock: ASX: CGS wb_incandescent



425 Smith Street

Suite 117

Fitzroy, VIC 3065


Phone: 61 3 9664 1300

Fax: 61 3 9664 1301